Biomanufacturing Excellence at Enhanced Speed and Quality
The 13th Edition of Biologics Manufacturing Korea 2024 continues to uphold its status as Korea's premier bioprocessing-focused conference, offering a targeted platform for regional biopharmaceutical industry stakeholders to foster strategic collaboration, gain exposure to cutting-edge manufacturing technologies, and share knowledge. This year's agenda is meticulously crafted to showcase success stories from Korea's leading biopharmas, coupled with insights from international biopharmas and major pharmaceutical companies.
The agenda for this year's Biologics Manufacturing Korea 2024 conference is thoughtfully designed to encapsulate the dynamic landscape of the South Korea biologics manufacturing market. It encompasses crucial themes such as upstream processing with a focus on high-throughput cell line development and cell culture, downstream processing involving product concentration and purification by chromatography, analytics and quality assurance, automation, Bioprocessing 4.0, and the digitalization landscape. The conference also features a dedicated showcase for Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs), emphasizing their contributions. Furthermore, the inclusion of sessions on Cell & Gene Therapy Manufacturing Excellence and a specific Case Study Session in this transformative field, along with discussions on facility design and capacity planning, solidifies the conference as a comprehensive platform for knowledge exchange and collaboration in the biologics manufacturing sector.
Building upon the success of previous editions, the conference aims to provide a comprehensive view of the rapidly evolving landscape of biologics manufacturing. Participants can look forward to engaging sessions, networking opportunities, and exposure to the latest industry trends. Join us for BMK 2024 to stay at the forefront of the biopharmaceutical industry's advancements and contribute to the collective knowledge sharing within the bioprocessing community.
This session involves a discussion among industry leaders to analyze the present status and future prospects of biologics manufacturing in South Korea, including market trends, regulatory landscape, and potential growth opportunities.
Explores advanced approaches and technologies for high-throughput cell line development and optimization of cell culture conditions to increase productivity and accelerate biologics manufacturing processes.
Explores techniques and methodologies for product concentration and purification using chromatography in downstream bioprocessing, emphasizing optimization strategies and emerging trends.
Explores the role of analytics and quality assurance in biopharmaceutical manufacturing, including process analytics, data integrity, and regulatory compliance to ensure product safety and efficacy.
This session explores the integration of automation, bioprocessing 4.0 technologies, and digitalization in biopharmaceutical manufacturing, highlighting advancements in process optimization, data analytics, and real-time monitoring for improved efficiency and quality.
Highlights the capabilities and offerings of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) in supporting biologics and/or cell and gene therapy production, showcasing their expertise in process development, scale-up, and commercialization.
Examines best practices and advancements in cell and gene therapy manufacturing, covering topics such as vector production, gene editing technologies, and process scale-up for commercialization.
Covers best practices and strategies for transferring technology from research to manufacturing scale and scaling up production processes efficiently while maintaining product quality and regulatory compliance.
Discusses considerations and strategies for fill-finish operations, facility design, and capacity planning in biopharmaceutical manufacturing to meet growing demand and ensure operational efficiency.
Limited Super (By 1st April 2024)
SGD 1,795
Limited Special (By 1st May 2024)
SGD 1,995
Early Bird (By 1st July 2024)
SGD 2,095
Standard Price
SGD 2,295
Limited Group Packages
Limited Super (By 1st April 2024)
SGD 3,595
Limited Special (By 1st May 2024)
SGD 3,795
Early Bird (By 1st July 2024)
SGD 3,995
Standard Price
SGD 4,095
Group Discount for Solution Providers & General Public: Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off
6:00 PM - 7:30 PM
13th August 2024
Songdo Convensia Convention Center, Incheon, South Korea
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2023 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.